Skip to main content

Table 4 The OAQI outcomes in various domains at baseline and 24 months for users and non-users of the updated ‘My Joint Pain’ website

From: My joint pain, a web-based resource, effects on education and quality of care at 24 months

  

Users (N = 35)

 

Non-Users (N = 87)

 
 

Baseline

12 months

24 months

Improvement from 12 to 24 months

Baseline

12 months

24 Months

Improvement from 12 to 24 months

eligible N (QI pass rate) a

eligible N (QI pass rate) a

eligible N (QI pass rate) a

N (%) a

eligible N (QI pass rate) a

eligible N (QI pass rate) a

eligible N (QI pass rate) +

N (%) a

P b

1. Disease development

17 (53%)

21 (66%)

21 (62%)

4 (13%)

39 (50%)

42 (45%)

49 (63%)

13 (19%)

0.46

2. Treatment alternatives

13 (42%)

22 (75%)

24 (71%)

6 (18%)

52 (62%)

46 (54%)

51 (59%)

17 (20%)

0.91

3. Self-management

16 (47%)

17 (53%)

24 (71%)

5 (16%)

40 (48%)

47 (55%)

44 (54%)

9 (11%)

0.11

4. Lifestyle

16 (47%)

20 (61%)

21 (64%)

5 (16%)

43 (50%)

51 (59%)

52 (63%)

14 (17%)

0.88

5. Physical activity

29 (85%)

30 (86%)

31 (89%)

4 (11%)

63 (73%)

78 (90%)

71 (84%)

4 (4%)

0.24

6. Referral physical activity

22 (63%)

20 (59%)

22 (65%)

5 (15%)

39 (45%)

47 (55%)

50 (59%)

14 (17%)

0.98

7. Weight reduction

17 (85%)

15 (68%)

13 (65%)

1 (5%)

43 (70%)

41 (71%)

42 (70%)

6 (11%)

0.67

8. Referral weight reduction

1 (5%)

5 (28%)

4 (22%)

2 (13%)

9 (16%)

16 (29%)

14 (26%)

5 (10%)

0.89

9. Functional assessment

10 (33%)

16 (55%)

8 (36%)

1 (5%)

29 (42%)

31 (48%)

28 (47%)

7 (14%)

0.16

10. Walking aid assessment

5 (26%)

10 (40%)

5 (29%)

0 (0%)

10 (17%)

16 (30%)

17 (36%)

4 (10%)

0.11

11. Other aids assessment

4 (27%)

3 (14%)

3 (19%)

2 (14%)

5 (10%)

8 (17%)

7 (17%)

4 (11%)

0.86

12. Pain assessment

20 (57%)

17 (53%)

17 (50%)

6 (19%)

53 (62%)

50 (58%)

43 (51%)

9 (11%)

0.73

13. Acetaminophen (Paracetamol)

23 (66%)

21 (60%)

29 (83%)

8 (23%)

68 (78%)

70 (82%)

67 (78%)

7 (8%)

<  0.05

14. Stronger pain killers

16 (53%)

19 (63%)

17 (63%)

4 (15%)

48 (60%)

44 (59%)

40 (58%)

5 (8%)

0.80

15. NSAIDs

18 (75%)

21 (70%)

22 (85%)

4 (15%)

50 (76%)

44 (79%)

43 (72%)

4 (8%)

0.15

16. Cortisone

14 (48%)

9 (36%)

8 (36%)

2 (10%)

30 (48%)

24 (43%)

18 (32%)

3 (7%)

0.31

17. Referral to orthopaedic surgeon

12 (55%)

14 (67%)

14 (74%)

2 (11%)

29 (46%)

32 (52%)

28(51%)

5 (11%)

0.78

  1. aNumber of eligible answers calculated as total number of yes and no answers (whose who did answered “not applicable” or “do not remember” answers were excluded); pass rate is the proportion of yes answers over the total number of eligible answers
  2. aImprovement in OAQI defined as those answered “no” at 12 months and answered “yes” at 24 months
  3. bData in bold indicates variables with a P value < 0.05 for changes in OAQI (negative, no change, positive) from 12 to 24 months between users and non-users
  4. OAQI Osteoarthritis Quality Indicator; NSAIDs non-steroidal anti-inflammatory drugs